SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016660
Filing Date
2022-08-11
Accepted
2022-08-11 08:05:49
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20220630.htm   iXBRL 10-Q 2280502
2 EX-31.1 vrca-ex31_1.htm EX-31.1 17140
3 EX-31.2 vrca-ex31_2.htm EX-31.2 17440
4 EX-32.1 vrca-ex32_1.htm EX-32.1 16000
  Complete submission text file 0000950170-22-016660.txt   7984470

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrca-20220630_lab.xml EX-101.LAB 419227
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrca-20220630_cal.xml EX-101.CAL 52352
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrca-20220630_def.xml EX-101.DEF 163529
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrca-20220630.xsd EX-101.SCH 42891
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrca-20220630_pre.xml EX-101.PRE 293111
56 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20220630_htm.xml XML 1520629
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 221153770
SIC: 2834 Pharmaceutical Preparations